Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Carl Lavie and Giuseppe Lippi.
Carl Lavie
Connection Strength
4.279
Giuseppe Lippi
  1. Cardiac Injury in COVID-19-Echoing Prognostication. J Am Coll Cardiol. 2020 11 03; 76(18):2056-2059.
    View in: PubMed
    Score: 0.911
  2. COVID-19 and obesity: links and risks. Expert Rev Endocrinol Metab. 2020 07; 15(4):215-216.
    View in: PubMed
    Score: 0.883
  3. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021 12 01; 6(12):1451-1460.
    View in: PubMed
    Score: 0.245
  4. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection. Ann Intern Med. 2021 06; 174(6):885-886.
    View in: PubMed
    Score: 0.237
  5. Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc. 2021 01; 96(1):203-217.
    View in: PubMed
    Score: 0.228
  6. In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19. Mayo Clin Proc. 2020 11; 95(11):2561-2563.
    View in: PubMed
    Score: 0.226
  7. Why is COVID-19 especially impacting the African American population? Ann Med. 2020 11; 52(7):331-333.
    View in: PubMed
    Score: 0.225
  8. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Clin Chem Lab Med. 2020 08 27; 58(9):1415-1422.
    View in: PubMed
    Score: 0.222
  9. In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Mayo Clin Proc. 2020 07; 95(7):1553-1556.
    View in: PubMed
    Score: 0.221
  10. Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. Mayo Clin Proc. 2020 07; 95(7):1445-1453.
    View in: PubMed
    Score: 0.221
  11. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. Mayo Clin Proc. 2020 06; 95(6):1222-1230.
    View in: PubMed
    Score: 0.219
  12. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 May - Jun; 63(3):390-391.
    View in: PubMed
    Score: 0.218
  13. Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. J Diabetes. 2020 Nov; 12(11):851-855.
    View in: PubMed
    Score: 0.057
  14. Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7. J Med Virol. 2021 02; 93(2):678-680.
    View in: PubMed
    Score: 0.057
  15. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis (Berl). 2020 05 26; 7(2):91-96.
    View in: PubMed
    Score: 0.055
  16. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis. Curr Probl Cardiol. 2020 Aug; 45(8):100617.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.